Vyteris

Vyteris, Inc. is a specialty pharmaceutical company developing and commercializing innovative technology for controlled delivery of peptide and small molecule therapeutics. Vyteris' first product, LidoSite®, which provides dermal analgesia prior to venipuncture (IV catheter insertions, blood draws, etc.) and superficial dermatological procedures, w... as the first FDA-approved active patch. Vyteris' proprietary transdermal drug delivery technology delivers drugs comfortably through the skin using low-level electrical energy. This active patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that can result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration.Read More